UBS Lux Equity Fund Biotech USD vs Invesco FTSE Emerging Markets High Dividend Low Volatility

UBS Lux Equity Fund Biotech USD vs Invesco FTSE Emerging Markets High Dividend Low Volatility

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Invesco FTSE Emerging Markets High Dividend Low Volatility

  • Security

    Invesco FTSE Emerging Markets High Dividend Low Volatility UCITS ETF Dist

  • Fee

    0.49%

  • ISIN

    IE00BYYXBF44

  • Holdings

    6

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with Invesco FTSE Emerging Markets High Dividend Low Volatility, we have 7 holdings where Vedanta is the largest holding (3.17), followed by ČEZ (2.44) and CEMIG (1.91).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Invesco FTSE Emerging Markets High Dividend Low Volatility.

UBS Lux Equity Fund Biotech USD Invesco FTSE Emerging Markets High Dividend Low Volatility
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Vedanta Ltd
India
3.17 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. ČEZ AS
Czech Republic
2.44 %
3. Moderna Inc
9.21 %
3. Companhia Energética de Minas Gerais ADR
Brazil
1.91 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. China Shenhua Energy Co Ltd Class H
China
1.9 %
5. AbbVie Inc
USA
5.52 %
5. China Petroleum & Chemical Corp Class H
China
1.73 %
6. Gilead Sciences Inc
USA
4.66 %
6. Bancolombia SA ADR
Colombia
1.52 %
7. Amgen Inc
4.32 %
-
8. BioNTech SE
4.13 %
-
9. Karuna Therapeutics Inc
3.75 %
-
10. Royalty Pharma Plc
3.28 %
-

The list of fund holdings was last updated on April 17, 2025.